Dosulepin Market, Global Outlook and Forecast 2022-2028

March 2022 | 70 pages | ID: D91A37BE7430EN
Market Monitor Global

Abstracts

Dosulepin (INN, BAN) formerly known as dothiepin (USAN), is a tricyclic antidepressant with anxiolytic properties that is used in several European and South Asian countries, as well as Australia, South Africa, and New Zealand

This report contains market size and forecasts of Dosulepin in global, including the following market information:

Global Dosulepin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dosulepin Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Dosulepin companies in 2021 (%)

The global Dosulepin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dosulepin include Ind-Swift, Intas, Taejoon Pharm, Abbott, Kaken Seiyaku, Teofarma, Crescent and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dosulepin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dosulepin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dosulepin Market Segment Percentages, by Type, 2021 (%)

• Tablets
• Capsules

Global Dosulepin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dosulepin Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drug Store

Global Dosulepin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dosulepin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dosulepin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Dosulepin revenues share in global market, 2021 (%)

Key companies Dosulepin sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Dosulepin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Ind-Swift
• Intas
• Taejoon Pharm
• Abbott
• Kaken Seiyaku
• Teofarma
• Crescent
• Mylan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dosulepin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dosulepin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DOSULEPIN OVERALL MARKET SIZE

2.1 Global Dosulepin Market Size: 2021 VS 2028
2.2 Global Dosulepin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dosulepin Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Dosulepin Players in Global Market
3.2 Top Global Dosulepin Companies Ranked by Revenue
3.3 Global Dosulepin Revenue by Companies
3.4 Global Dosulepin Sales by Companies
3.5 Global Dosulepin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dosulepin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dosulepin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dosulepin Players in Global Market
  3.8.1 List of Global Tier 1 Dosulepin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Dosulepin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dosulepin Market Size Markets, 2021 & 2028
  4.1.2 Tablets
  4.1.3 Capsules
4.2 By Type - Global Dosulepin Revenue & Forecasts
  4.2.1 By Type - Global Dosulepin Revenue, 2017-2022
  4.2.2 By Type - Global Dosulepin Revenue, 2023-2028
  4.2.3 By Type - Global Dosulepin Revenue Market Share, 2017-2028
4.3 By Type - Global Dosulepin Sales & Forecasts
  4.3.1 By Type - Global Dosulepin Sales, 2017-2022
  4.3.2 By Type - Global Dosulepin Sales, 2023-2028
  4.3.3 By Type - Global Dosulepin Sales Market Share, 2017-2028
4.4 By Type - Global Dosulepin Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dosulepin Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Drug Store
5.2 By Application - Global Dosulepin Revenue & Forecasts
  5.2.1 By Application - Global Dosulepin Revenue, 2017-2022
  5.2.2 By Application - Global Dosulepin Revenue, 2023-2028
  5.2.3 By Application - Global Dosulepin Revenue Market Share, 2017-2028
5.3 By Application - Global Dosulepin Sales & Forecasts
  5.3.1 By Application - Global Dosulepin Sales, 2017-2022
  5.3.2 By Application - Global Dosulepin Sales, 2023-2028
  5.3.3 By Application - Global Dosulepin Sales Market Share, 2017-2028
5.4 By Application - Global Dosulepin Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dosulepin Market Size, 2021 & 2028
6.2 By Region - Global Dosulepin Revenue & Forecasts
  6.2.1 By Region - Global Dosulepin Revenue, 2017-2022
  6.2.2 By Region - Global Dosulepin Revenue, 2023-2028
  6.2.3 By Region - Global Dosulepin Revenue Market Share, 2017-2028
6.3 By Region - Global Dosulepin Sales & Forecasts
  6.3.1 By Region - Global Dosulepin Sales, 2017-2022
  6.3.2 By Region - Global Dosulepin Sales, 2023-2028
  6.3.3 By Region - Global Dosulepin Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Dosulepin Revenue, 2017-2028
  6.4.2 By Country - North America Dosulepin Sales, 2017-2028
  6.4.3 US Dosulepin Market Size, 2017-2028
  6.4.4 Canada Dosulepin Market Size, 2017-2028
  6.4.5 Mexico Dosulepin Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Dosulepin Revenue, 2017-2028
  6.5.2 By Country - Europe Dosulepin Sales, 2017-2028
  6.5.3 Germany Dosulepin Market Size, 2017-2028
  6.5.4 France Dosulepin Market Size, 2017-2028
  6.5.5 U.K. Dosulepin Market Size, 2017-2028
  6.5.6 Italy Dosulepin Market Size, 2017-2028
  6.5.7 Russia Dosulepin Market Size, 2017-2028
  6.5.8 Nordic Countries Dosulepin Market Size, 2017-2028
  6.5.9 Benelux Dosulepin Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Dosulepin Revenue, 2017-2028
  6.6.2 By Region - Asia Dosulepin Sales, 2017-2028
  6.6.3 China Dosulepin Market Size, 2017-2028
  6.6.4 Japan Dosulepin Market Size, 2017-2028
  6.6.5 South Korea Dosulepin Market Size, 2017-2028
  6.6.6 Southeast Asia Dosulepin Market Size, 2017-2028
  6.6.7 India Dosulepin Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Dosulepin Revenue, 2017-2028
  6.7.2 By Country - South America Dosulepin Sales, 2017-2028
  6.7.3 Brazil Dosulepin Market Size, 2017-2028
  6.7.4 Argentina Dosulepin Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Dosulepin Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Dosulepin Sales, 2017-2028
  6.8.3 Turkey Dosulepin Market Size, 2017-2028
  6.8.4 Israel Dosulepin Market Size, 2017-2028
  6.8.5 Saudi Arabia Dosulepin Market Size, 2017-2028
  6.8.6 UAE Dosulepin Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Ind-Swift
  7.1.1 Ind-Swift Corporate Summary
  7.1.2 Ind-Swift Business Overview
  7.1.3 Ind-Swift Dosulepin Major Product Offerings
  7.1.4 Ind-Swift Dosulepin Sales and Revenue in Global (2017-2022)
  7.1.5 Ind-Swift Key News
7.2 Intas
  7.2.1 Intas Corporate Summary
  7.2.2 Intas Business Overview
  7.2.3 Intas Dosulepin Major Product Offerings
  7.2.4 Intas Dosulepin Sales and Revenue in Global (2017-2022)
  7.2.5 Intas Key News
7.3 Taejoon Pharm
  7.3.1 Taejoon Pharm Corporate Summary
  7.3.2 Taejoon Pharm Business Overview
  7.3.3 Taejoon Pharm Dosulepin Major Product Offerings
  7.3.4 Taejoon Pharm Dosulepin Sales and Revenue in Global (2017-2022)
  7.3.5 Taejoon Pharm Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott Dosulepin Major Product Offerings
  7.4.4 Abbott Dosulepin Sales and Revenue in Global (2017-2022)
  7.4.5 Abbott Key News
7.5 Kaken Seiyaku
  7.5.1 Kaken Seiyaku Corporate Summary
  7.5.2 Kaken Seiyaku Business Overview
  7.5.3 Kaken Seiyaku Dosulepin Major Product Offerings
  7.5.4 Kaken Seiyaku Dosulepin Sales and Revenue in Global (2017-2022)
  7.5.5 Kaken Seiyaku Key News
7.6 Teofarma
  7.6.1 Teofarma Corporate Summary
  7.6.2 Teofarma Business Overview
  7.6.3 Teofarma Dosulepin Major Product Offerings
  7.6.4 Teofarma Dosulepin Sales and Revenue in Global (2017-2022)
  7.6.5 Teofarma Key News
7.7 Crescent
  7.7.1 Crescent Corporate Summary
  7.7.2 Crescent Business Overview
  7.7.3 Crescent Dosulepin Major Product Offerings
  7.7.4 Crescent Dosulepin Sales and Revenue in Global (2017-2022)
  7.7.5 Crescent Key News
7.8 Mylan
  7.8.1 Mylan Corporate Summary
  7.8.2 Mylan Business Overview
  7.8.3 Mylan Dosulepin Major Product Offerings
  7.8.4 Mylan Dosulepin Sales and Revenue in Global (2017-2022)
  7.8.5 Mylan Key News

8 GLOBAL DOSULEPIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Dosulepin Production Capacity, 2017-2028
8.2 Dosulepin Production Capacity of Key Manufacturers in Global Market
8.3 Global Dosulepin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DOSULEPIN SUPPLY CHAIN ANALYSIS

10.1 Dosulepin Industry Value Chain
10.2 Dosulepin Upstream Market
10.3 Dosulepin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Dosulepin Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Dosulepin in Global Market
Table 2. Top Dosulepin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Dosulepin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Dosulepin Revenue Share by Companies, 2017-2022
Table 5. Global Dosulepin Sales by Companies, (K Units), 2017-2022
Table 6. Global Dosulepin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Dosulepin Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Dosulepin Product Type
Table 9. List of Global Tier 1 Dosulepin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dosulepin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dosulepin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Dosulepin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Dosulepin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Dosulepin Sales (K Units), 2017-2022
Table 15. By Type - Global Dosulepin Sales (K Units), 2023-2028
Table 16. By Application – Global Dosulepin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Dosulepin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Dosulepin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Dosulepin Sales (K Units), 2017-2022
Table 20. By Application - Global Dosulepin Sales (K Units), 2023-2028
Table 21. By Region – Global Dosulepin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Dosulepin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Dosulepin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Dosulepin Sales (K Units), 2017-2022
Table 25. By Region - Global Dosulepin Sales (K Units), 2023-2028
Table 26. By Country - North America Dosulepin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Dosulepin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Dosulepin Sales, (K Units), 2017-2022
Table 29. By Country - North America Dosulepin Sales, (K Units), 2023-2028
Table 30. By Country - Europe Dosulepin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Dosulepin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Dosulepin Sales, (K Units), 2017-2022
Table 33. By Country - Europe Dosulepin Sales, (K Units), 2023-2028
Table 34. By Region - Asia Dosulepin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Dosulepin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Dosulepin Sales, (K Units), 2017-2022
Table 37. By Region - Asia Dosulepin Sales, (K Units), 2023-2028
Table 38. By Country - South America Dosulepin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Dosulepin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Dosulepin Sales, (K Units), 2017-2022
Table 41. By Country - South America Dosulepin Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Dosulepin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Dosulepin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Dosulepin Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Dosulepin Sales, (K Units), 2023-2028
Table 46. Ind-Swift Corporate Summary
Table 47. Ind-Swift Dosulepin Product Offerings
Table 48. Ind-Swift Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Intas Corporate Summary
Table 50. Intas Dosulepin Product Offerings
Table 51. Intas Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Taejoon Pharm Corporate Summary
Table 53. Taejoon Pharm Dosulepin Product Offerings
Table 54. Taejoon Pharm Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Abbott Corporate Summary
Table 56. Abbott Dosulepin Product Offerings
Table 57. Abbott Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Kaken Seiyaku Corporate Summary
Table 59. Kaken Seiyaku Dosulepin Product Offerings
Table 60. Kaken Seiyaku Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Teofarma Corporate Summary
Table 62. Teofarma Dosulepin Product Offerings
Table 63. Teofarma Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Crescent Corporate Summary
Table 65. Crescent Dosulepin Product Offerings
Table 66. Crescent Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Mylan Corporate Summary
Table 68. Mylan Dosulepin Product Offerings
Table 69. Mylan Dosulepin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Dosulepin Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Dosulepin Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Dosulepin Production by Region, 2017-2022 (K Units)
Table 73. Global Dosulepin Production by Region, 2023-2028 (K Units)
Table 74. Dosulepin Market Opportunities & Trends in Global Market
Table 75. Dosulepin Market Drivers in Global Market
Table 76. Dosulepin Market Restraints in Global Market
Table 77. Dosulepin Raw Materials
Table 78. Dosulepin Raw Materials Suppliers in Global Market
Table 79. Typical Dosulepin Downstream
Table 80. Dosulepin Downstream Clients in Global Market
Table 81. Dosulepin Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Dosulepin Segment by Type
Figure 2. Dosulepin Segment by Application
Figure 3. Global Dosulepin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dosulepin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dosulepin Revenue, 2017-2028 (US$, Mn)
Figure 7. Dosulepin Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dosulepin Revenue in 2021
Figure 9. By Type - Global Dosulepin Sales Market Share, 2017-2028
Figure 10. By Type - Global Dosulepin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Dosulepin Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Dosulepin Sales Market Share, 2017-2028
Figure 13. By Application - Global Dosulepin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Dosulepin Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Dosulepin Sales Market Share, 2017-2028
Figure 16. By Region - Global Dosulepin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Dosulepin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Dosulepin Sales Market Share, 2017-2028
Figure 19. US Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Dosulepin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Dosulepin Sales Market Share, 2017-2028
Figure 24. Germany Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 25. France Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Dosulepin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Dosulepin Sales Market Share, 2017-2028
Figure 33. China Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 37. India Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Dosulepin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Dosulepin Sales Market Share, 2017-2028
Figure 40. Brazil Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Dosulepin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Dosulepin Sales Market Share, 2017-2028
Figure 44. Turkey Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Dosulepin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Dosulepin Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Dosulepin by Region, 2021 VS 2028
Figure 50. Dosulepin Industry Value Chain
Figure 51. Marketing Channels